| USP | United States Pharmacopeial convention = United States Pharmacopeia; 미국 약전 |
|---|---|
| USP DI | United States Pharmacopeial convention Dispensing Information |
| USPC | United States Pharmacopeia Convention |
| Geneva Convention | An international agreement formed at meetings in Geneva, Switzerland, in 1864 and 1906, relating (among medical subjects) to the safeguarding of the wounded in battle, of those having the care of them, and of the buildings in which they are being treated. The direct outcome of the first of these meetings was the establishment of the Red Cross Society. (05 Mar 2000) |
|---|---|
| Cleland nomenclature | A nomenclature for representing the binding mechanisms of enzyme-catalyzed reactions; in this nomenclature, substrates are represented by the letters A, B, C, etc., while products are represented by P, Q, R, etc., enzyme by E, and modified forms of the enzyme by F, G, etc.; in addition, the number of substrates or products is represented by uni, bi, ter, etc.; thus, an aminotransferase reaction (e.g., alanine transaminase) has a ping-pong bi bi mechanism; glutamine synthetase has been reported to have a random ter ter mechanism.subentries under mechanism. (05 Mar 2000) |
| Cleland's reagent | <chemical> A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of sh (thiol) groups and for reducing disulphides to dithiols. Pharmacological action: sulfhydryl reagents, expectorants. Chemical name: 2,3-Butanediol, 1,4-dimercapto-, (R*,R*)- (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|